Valuation : Kim Forest Enterprise Co., Ltd.

Market Cap 779M 24.58M 21.1M 19.76M 18.09M 34.08M 2.35B 34.18M 234M 91.46M 1.18B 92.3M 90.31M 3.92B P/E 2024
-7.91x
P/E 2025 -7.34x
Enterprise Value 1.04B 32.79M 28.15M 26.35M 24.13M 45.46M 3.13B 45.59M 312M 122M 1.58B 123M 120M 5.22B EV / Sales 2024
2.86x
EV / Sales 2025 2.43x
Free-Float
43.95%
Yield 2024 *
-
Yield 2025 -
1 day+0.77%
1 week+1.95%
Current month-1.87%
1 month-5.42%
3 months+11.02%
6 months-25.57%
Current year-25.99%
1 week 12.85
Extreme 12.85
13.25
1 month 11.75
Extreme 11.75
14.1
Current year 11.4
Extreme 11.4
18.5
1 year 11.4
Extreme 11.4
26.45
3 years 11.4
Extreme 11.4
48.1
5 years 11.4
Extreme 11.4
50.38
10 years 8.27
Extreme 8.27329
122.57
Manager TitleAgeSince
Chief Executive Officer - 30/06/2005
Director of Finance/CFO - 01/12/2013
Chief Tech/Sci/R&D Officer - 31/10/2016
Director TitleAgeSince
Chairman - 21/09/2014
Director/Board Member - 27/07/2004
Director/Board Member - 28/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
+0.77%+1.95%-32.47%-67.17% 24.58M
+2.04%+4.88%-37.10%-39.05% 657M
+2.81%-8.80%+82.76% - 348M
-7.13%-2.58%-36.21%-9.46% 132M
+5.56%+5.03%-14.34%+32.28% 82.34M
Average +0.81%+0.94%-7.48%-20.85% 248.82M
Weighted average by Cap. +1.49%-1.08%-1.87%-28.92%

Financials

2024 2025
Net sales 502M 15.83M 13.59M 12.72M 11.65M 21.94M 1.51B 22M 151M 58.88M 762M 59.43M 58.14M 2.52B 549M 17.33M 14.88M 13.93M 12.75M 24.03M 1.66B 24.09M 165M 64.47M 834M 65.07M 63.66M 2.76B
Net income -160M -5.05M -4.33M -4.06M -3.71M -6.99M -482M -7.01M -48.02M -18.77M -243M -18.94M -18.54M -804M -146M -4.62M -3.97M -3.71M -3.4M -6.41M -441M -6.43M -43.99M -17.19M -222M -17.35M -16.98M -736M
Net Debt 147M 4.62M 3.97M 3.72M 3.4M 6.41M 442M 6.43M 44M 17.2M 223M 17.36M 16.98M 737M 260M 8.21M 7.05M 6.6M 6.04M 11.38M 784M 11.41M 78.13M 30.54M 395M 30.82M 30.16M 1.31B
Logo Kim Forest Enterprise Co., Ltd.
KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
Employees
-
Date Price Change Volume
27/08/26 NT$12.90 -0.39% 5,707
26/08/26 NT$12.95 -1.15% 18,758
25/08/26 NT$13.10 +0.77% 16,340
24/08/26 NT$13.00 -0.38% 10,000
21/08/26 NT$13.05 +1.16% 6,202
  1. Stock Market
  2. Stocks
  3. 6645 Stock